CLINICAL_TRIALS
trial_result
· 2009-02-10
Clinical Trial Update: Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM) [Phase 1]
Summary
Phase 1 safety study of BMS-767778 in healthy subjects and subjects with Type 2 Diabetes Mellitus was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: TERMINATED